IMUX Stock Analysis: Buy, Sell, or Hold?
IMUX - Immunic, Inc. Common Stock
$1.15
0.04 (3.60%)
▲
5d:
-12.88%
30d:
+7.48%
90d:
+125.4%
WAIT
LOW Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 21, 2026
Smart Money Distribution
IMUX is up 4.2% this week, but smart money is buying puts. Top strike: $1.5 2026-05-15 with 1 OI. Put ratio: 100% View Scanner →
Strength: 7.1/10
Get Alerted When IMUX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: IMUX is down 12.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: IMUX is down 12.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: IMUX is currently trading at $1.15, which is considered fair relative to its 30-day fair value range of $1.00 to $1.28.
Technical Outlook: Technically, IMUX is in a strong uptrend. Immediate support is located at $1.03, while resistance sits at $1.35. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.25 (+356.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IMUX is in a strong uptrend. Immediate support is located at $1.03, while resistance sits at $1.35. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.25 (+356.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.00 -
$1.28
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 356.5% below Wall St target ($5.25)
- WARNING: Recommendation downgraded due to -12.9% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.00 -
$1.28
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.03
Resistance Level
$1.35
Current Trend
Strong Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.31
Wall Street Target
$5.25
(+356.5%)
Share & Embed Analysis
Last updated: April 02, 2026 12:25 AM ET
Data refreshes hourly during market hours. Next update: 1:25 AM
Data refreshes hourly during market hours. Next update: 1:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMUX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$25 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 52 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 66 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 52 HOLD |
